Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodoros P Vassilakopoulos

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
The Lancet. Oncology|April 1, 2021
Relapsed or refractory classical Hodgkin lymphoma: which immunotherapy, and when?Theodoros P Vassilakopoulos
Seminars in Hematology|August 7, 2016
Hodgkin lymphoma: IntroductionAndreas Engert, Theodoros P Vassilakopoulos
Blood|April 25, 2024
ThrombocytosisAthanasios Liaskas, Theodoros P Vassilakopoulos
British Journal of Haematology|May 16, 2026
Is universal CAR T-cell referral absolutely required for transplant-ineligible patients with primary refractory or early relapsed DLBCL?Maria Dimou, Theodoros P Vassilakopoulos
Blood|April 22, 2021
Rapidly deteriorating B-CLL at presentation: clonally related Burkitt leukemia as an atypical Richter transformation?Chrysovalantou Chatzidimitriou, Theodoros P Vassilakopoulos
Seminars in Hematology|March 20, 2013
Advanced and relapsed/refractory Hodgkin lymphoma: what has been achieved during the last 50 yearsTheodoros P Vassilakopoulos, Maria K Angelopoulou
Seminars in Hematology|August 7, 2016
Treatment of advanced-stage Hodgkin lymphomaTheodoros P Vassilakopoulos, Peter W M Johnson
Translational Pediatrics|February 3, 2016
Omitting or reducing radiotherapy in childhood or adolescence Hodgkin LymphomaTheodoros P Vassilakopoulos, Georgios Boutsikas, Vassilios Papadakis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2016
HD2000 Update in Hodgkin Lymphoma-ABVD or BEACOPP?Theodoros P Vassilakopoulos, Peter W M Johnson
Haematologica|November 2, 2015
Comment on "Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial"Theodoros P Vassilakopoulos, John Apostolidis, Maria K Angelopoulou
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
The Lancet. Oncology|April 1, 2021
Relapsed or refractory classical Hodgkin lymphoma: which immunotherapy, and when?Theodoros P Vassilakopoulos
Seminars in Hematology|August 7, 2016
Hodgkin lymphoma: IntroductionAndreas Engert, Theodoros P Vassilakopoulos
Blood|April 25, 2024
ThrombocytosisAthanasios Liaskas, Theodoros P Vassilakopoulos
British Journal of Haematology|May 16, 2026
Is universal CAR T-cell referral absolutely required for transplant-ineligible patients with primary refractory or early relapsed DLBCL?Maria Dimou, Theodoros P Vassilakopoulos
Blood|April 22, 2021
Rapidly deteriorating B-CLL at presentation: clonally related Burkitt leukemia as an atypical Richter transformation?Chrysovalantou Chatzidimitriou, Theodoros P Vassilakopoulos
Seminars in Hematology|March 20, 2013
Advanced and relapsed/refractory Hodgkin lymphoma: what has been achieved during the last 50 yearsTheodoros P Vassilakopoulos, Maria K Angelopoulou
Seminars in Hematology|August 7, 2016
Treatment of advanced-stage Hodgkin lymphomaTheodoros P Vassilakopoulos, Peter W M Johnson
Translational Pediatrics|February 3, 2016
Omitting or reducing radiotherapy in childhood or adolescence Hodgkin LymphomaTheodoros P Vassilakopoulos, Georgios Boutsikas, Vassilios Papadakis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2016
HD2000 Update in Hodgkin Lymphoma-ABVD or BEACOPP?Theodoros P Vassilakopoulos, Peter W M Johnson
Haematologica|November 2, 2015
Comment on "Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial"Theodoros P Vassilakopoulos, John Apostolidis, Maria K Angelopoulou
Pageof 20